That company is actually working on uplisting because it knows the OTC is a curse to company. The RS just took place. I am keeping fingers crossed that an ul will happen by September. And that company has a lot more going for it than Regen at this point.
Btw, AMB* actually applied for orphan status before ever actually submitting an IND and received it from both FDA and Europe Medicines Agency for one indication of their MANF molecule. I didn't know one could do that but they did.
Market Data 
Markets 
AI
